Detailed price information for Eli Lilly and Company (LLY-N) from The Globe and Mail including charting and trades.

Eli Lilly 's ( LLY +1.58%) share price has soared over the past five years (up 530%). In fact, it's hard to find a single ...

Eli Lilly’s stock has recently seen its consensus analyst price target rise from $1,003 to $1,024. This change reflects ...

J PMorgan Chase (JPM) is pounding the table on the stock of Eli Lilly & Co. (LLY) after its market capitalization recently surpassed $1 trillion.

Detailed price information for Eli Lilly and Company (LLY-N) from The Globe and Mail including charting and trades.

Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include ...

Eli Lilly (NYSE:LLY) shares rose about 2% on early Thursday after the company said a pivotal study for its experimental ...

Financial giants have made a conspicuous bullish move on Eli Lilly. Our analysis of options history for Eli Lilly (NYSE:LLY) revealed 46 unusual trades. Delving into the details, we found 41% of ...

Biotech Structure Therapeutics’ (GPCR) shares rallied 102.49% on Monday after mid-stage data for its obesity pill topped ...

French biotech company Abivax's shares rose by over 20% on Wednesday on market rumours that U.S. pharma giant Eli Lilly could ...

The pharmaceutical giant Eli Lilly has once again raised the bar in the highly competitive obesity treatment market. New clinical trial data for its experime ...

Lilly’s closely watched retatrutide spurred as much as 29% weight loss in a Phase 3 study, a finding that is “raising the bar ...